Cite
Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma
MLA
Jian Yi Li, et al. “Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.” The Journal of Clinical Endocrinology and Metabolism, vol. 104, no. 6, Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0eb500147fa7171a4d4510a4ea7dcf69&authtype=sso&custid=ns315887.
APA
Jian Yi Li, Zhenggang Xiong, William H. Yong, Sergey Mareninov, Qinwen Mao, Jiang Qian, Cynthia T. Welsh, Kathy L. Newell, Sarah S R Kim, Daniel F. Kelly, Paul E. McKeever, Richard M. Green, Timothy F. Cloughesy, Anthony P. Heaney, Masoud Movassaghi, Fausto J. Rodriguez, Dongyun Zhang, & Sylvia L. Asa. (2018). Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma. The Journal of Clinical Endocrinology and Metabolism, 104(6).
Chicago
Jian Yi Li, Zhenggang Xiong, William H. Yong, Sergey Mareninov, Qinwen Mao, Jiang Qian, Cynthia T. Welsh, et al. 2018. “Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.” The Journal of Clinical Endocrinology and Metabolism 104 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0eb500147fa7171a4d4510a4ea7dcf69&authtype=sso&custid=ns315887.